Biotech Nephrogen combines AI and gene therapy to reverse kidney disease — check it out at TechCrunch Disrupt 2025
Update: 2025-10-28
Description
From patient to pioneer: Witness Demetri Maxim's race against time at TechCrunch Disrupt. Facing his own inherited kidney disease, this founder is revolutionizing gene therapy delivery with AI, aiming for a cure, and plans to be his own first patient. Will Nephrogen's breakthrough change the future for one in seven Americans with chronic kidney disease?
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel




